The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha
Open accessAbstract
Recent studies indicate that a peroxisome proliferator-activated receptor, PPAR gamma, functions as an important adipocyte determination factor. In contrast, tumor necrosis factor-alpha (TNF alpha) inhibits adipogenesis, causes dedifferentiation of mature adipocytes, and reduces the expression of several adipocyte-specific genes. Here, we report that treatment of 3T3-L1 adipocytes with TNF alpha resulted in a time- and concentration-dependent decrease in PPAR gamma mRNA expression to the level detected in preadipocytes. PPAR gamma mRNA levels were reduced by 95% with 3 nM TNF alpha treatment for 24 h. Half-maximal effects were seen after 3 h treatment with 3 nM TNF alpha or with 50 pM TNF alpha (24-h exposure). Parallel reductions in PPAR gamma protein levels were also observed after treatment of 3T3-L1 adipocytes with TNF alpha. Using a ribonuclease protection assay, both alternatively spliced PPAR gamma isoforms (gamma 1 and gamma 2) were shown to be negatively regulated by TNF alpha. The down-regulation of PPAR gamma by TNF-alpha preceded the diminution in expression of other adipocyte-specific genes including CCAAT/enhancer binding protein and adipocyte fatty acid-binding protein (aP2). The effect of TNF alpha was specific for the gamma-isoform of PPARs, since the expression of PPAR delta mRNA was not affected by treatment with TNF alpha. Low level constitutive expression of PPAR gamma in 3T3-L1 adipocytes (at levels approximately 2- to 3-fold higher than in preadipocytes) partially blocked the inhibitory effect of TNF alpha on aP2 and adipsin expression. These findings support the following conclusions: 1) PPAR gamma expression is necessary for the maintenance of the adipocyte phenotype. 2) PPAR gamma, but not PPAR delta, expression is sufficient to attenuate TNF alpha-mediated effects on adipocyte phenotype. 3) Reduced PPAR gamma gene expression is likely to represent an important component of the mechanism by which TNF alpha exerts its antiadipogenic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Green, H., & Kehinde, O. (1975) · Cell · doi:10.1016/0092-8674(75)90087-2 · Cited by 1,360
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
An established pre-adipose cell line and its differentiation in culture
Green, H., & Meuth, M. (1974) · Cell · doi:10.1016/0092-8674(74)90116-0 · Cited by 1,111
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Chawla, A., Schwarz, E. J., Dimaculangan, D. D., & Lazar, M. A. (1994) · Endocrinology · doi:10.1210/en.135.2.798 · Cited by 873
A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of Cachexia
Torti, F. M., Dieckmann, B., Beutler, B., Cerami, A., & Ringold, G. M. (1985) · Science · doi:10.1126/science.3839597 · Cited by 518
Schmidt, A. (1992) · Molecular Endocrinology · doi:10.1210/me.6.10.1634 · Cited by 477
Differential activation of adipogenesis by multiple PPAR isoforms.
Brun, R. P., Tontonoz, P., Forman, B. M., Ellis, R., Chen, J., Evans, R. M., & Spiegelman, B. M. (1996) · Genes & Development · doi:10.1101/gad.10.8.974 · Cited by 474
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80025-5 · Cited by 458
Freytag, S. O., Paielli, D. L., & Gilbert, J. D. (1994) · Genes & Development · doi:10.1101/gad.8.14.1654 · Cited by 456
Zhu, Y., Alvares, K., Huang, Q., Rao, M. S., & Reddy, J. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74184-2 · Cited by 374
Stephens, J. M., & Pekala, P. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54714-1 · Cited by 370
Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
Kletzien, R. F., Clarke, S. D., & Ulrich, R. G. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08890-x · Cited by 284
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
Patton, J. S., Shepard, H. M., Wilking, H., Lewis, G., Aggarwal, B. B., Eessalu, T. E., Gavin, L. A., & Grunfeld, C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8313 · Cited by 277
Hauner, H., Petruschke, T., Russ, M., Röhrig, K., & Eckel, J. (1995) · Diabetologia · doi:10.1007/s001250050350 · Cited by 262
BEUTLER, B., & CERAMI, A. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-57 · Cited by 251
Through thick and thin: Wasting, obesity, and TNFα
Spiegelman, B. M., & Hotamisligil, G. S. (1993) · Cell · doi:10.1016/0092-8674(93)90243-j · Cited by 217
Torti, F. M., Torti, S. V., Larrick, J. W., & Ringold, G. M. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.3.1105 · Cited by 186
KAWAKAMI, M., MURASE, T., OGAMA, H., ISHIBASHI, S., MORI, N., TAKAKU, F., & SHIBATA, S. (1987) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a121917 · Cited by 183
Szalkowski, D. (1995) · Endocrinology · doi:10.1210/en.136.4.1474 · Cited by 176
Chen, F., Law, S. W. T., & O’Malley, B. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2302 · Cited by 156
Ron, D., Brasier, A. R., McGehee, R. E., & Habener, J. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115566 · Cited by 152
Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians.
Norman, R. A., Bogardus, C., & Ravussin, É. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118016 · Cited by 127
Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor
Cornelius, P. K., Enerbäck, S., Bjursell, G., Olivecrona, T., & Pekala, P. H. (1988) · Biochemical Journal · doi:10.1042/bj2490765 · Cited by 119
Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes
Marshall, M. K., Doerrler, W. T., Feingold, K. R., & Grünfeld, C. (1994) · Endocrinology · doi:10.1210/en.135.1.141 · Cited by 72
Ogawa, H., Nielsen, S., & Kawakami, M. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90246-4 · Cited by 50
Ninomiya‐Tsuji, J., Torti, F. M., & RINGOLD, G. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9611 · Cited by 38
Pape, M. E., & Kim, K. H. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.974-982.1989 · Cited by 37
Price, S. R., Olivecrona, T., & Pekala, P. H. (1986) · Biochemical Journal · doi:10.1042/bj2400601 · Cited by 32
Mackay, A. G., Oliver, J. D., & Rogers, M. P. (1990) · Biochemical Journal · doi:10.1042/bj2690123 · Cited by 28
Cited by
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
(1998) · PubMed · Cited by 2,737
Understanding Adipocyte Differentiation
GREGOIRE, F. M., SMAS, C. M., & SUL, H. S. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.3.783 · Cited by 2,376
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
“In cardiac muscle, our laboratory recently reported that LPS administration decreases RXR- , - , and - and PPAR- and - / expression (192) (Table 4).”
Influential
Metadata
- Authors
- Zhang, B.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1996-11-01
- Volume
- 10
- Issue
- 11
- Pages
- 1457-1466
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2118190725
- Cited by
- 332
- References
- 36
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.